{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Eculizumab可能导致不良表型",
            "expectation": "如果确认存在，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Ravulizumab可能导致不良表型",
            "expectation": "如果确认存在，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Aflibercept可能导致不良表型",
            "expectation": "如果确认存在，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_a_hus",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_cd5",
          "type": "Target",
          "label": "CD5",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inhibition",
          "type": "Pathway",
          "label": "Inhibition Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_eculizumab",
          "type": "Target",
          "label": "OffTarget_Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_eculizumab",
          "type": "Pathway",
          "label": "RiskPathway_Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_eculizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ravulizumab",
          "type": "Target",
          "label": "OffTarget_Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ravulizumab",
          "type": "Pathway",
          "label": "RiskPathway_Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ravulizumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_aflibercept",
          "type": "Target",
          "label": "OffTarget_Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_aflibercept",
          "type": "Pathway",
          "label": "RiskPathway_Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_aflibercept",
          "type": "Phenotype",
          "label": "AdversePhenotype_Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Aflibercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Copanlisib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Belimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sunitinib",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "target_cd5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Eculizumab对CD5的已知作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "target_cd5",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Ravulizumab对CD5的已知作用"
        },
        {
          "source": "drug_aflibercept",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "有文献支持其通过通路抑制影响疾病"
        },
        {
          "source": "drug_corticosteroids",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "普遍接受的药理作用"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "d_a_hus",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过血液净化机制支持疾病改善"
        },
        {
          "source": "drug_methotrexate",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "推测作用于相关免疫通路"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "target_cd5",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "有研究表明其对CD5的抑制作用"
        },
        {
          "source": "drug_tacrolimus",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "推测作用于抑制免疫途径"
        },
        {
          "source": "drug_copanlisib",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "潜在影响相关的细胞通路"
        },
        {
          "source": "drug_rituximab",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "文献中表明对相关免疫途径的影响"
        },
        {
          "source": "drug_belimumab",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可能有助于症状改善"
        },
        {
          "source": "drug_sunitinib",
          "target": "pathway_inhibition",
          "relation": "modulates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "推测可影响血管生成相关通路"
        },
        {
          "source": "d_a_hus",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "药物对疾病的已知效用"
        },
        {
          "source": "d_a_hus",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "药物对疾病的已知效用"
        },
        {
          "source": "drug_eculizumab",
          "target": "n_ot_eculizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_eculizumab",
          "target": "n_rp_eculizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_eculizumab",
          "target": "n_adv_eculizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_eculizumab",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立将抵消净获益"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_ot_ravulizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_ravulizumab",
          "target": "n_rp_ravulizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_ravulizumab",
          "target": "n_adv_ravulizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_ravulizumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立将抵消净获益"
        },
        {
          "source": "drug_aflibercept",
          "target": "n_ot_aflibercept",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_aflibercept",
          "target": "n_rp_aflibercept",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_aflibercept",
          "target": "n_adv_aflibercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_aflibercept",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立将抵消净获益"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "set_weights": [
            {
              "edge_id": "n_adv_eculizumab-H1",
              "weight": 0.85,
              "rationale": "风险成立将抵消净获益"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "Eculizumab的反向作用",
              "pro_nodes": [
                "d_a_hus",
                "drug_eculizumab"
              ],
              "con_nodes": [
                "n_adv_eculizumab"
              ],
              "note": "疗效可能被潜在不良反应抵消"
            }
          ]
        },
        "notes": "已完成安全性压力测试：以高权重 refutes 边连到假设"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "set_weights": [
            {
              "edge_id": "n_adv_ravulizumab-H2",
              "weight": 0.85,
              "rationale": "风险成立将抵消净获益"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "Ravulizumab的反向作用",
              "pro_nodes": [
                "d_a_hus",
                "drug_ravulizumab"
              ],
              "con_nodes": [
                "n_adv_ravulizumab"
              ],
              "note": "疗效可能被潜在不良反应抵消"
            }
          ]
        },
        "notes": "已完成安全性压力测试：以高权重 refutes 边连到假设"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "set_weights": [
            {
              "edge_id": "n_adv_aflibercept-H3",
              "weight": 0.85,
              "rationale": "风险成立将抵消净获益"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "Aflibercept的反向作用",
              "pro_nodes": [
                "d_a_hus",
                "drug_aflibercept"
              ],
              "con_nodes": [
                "n_adv_aflibercept"
              ],
              "note": "疗效可能被潜在不良反应抵消"
            }
          ]
        },
        "notes": "已完成安全性压力测试：以高权重 refutes 边连到假设"
      }
    ],
    "residual_conflicts": [
      "急性/慢性效应的方向性仍未消解",
      "与其他治疗的潜在交互作用未覆盖"
    ]
  }
}